BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Beach

  Simulations Plus Releases GastroPlus™ Version 9.6

  Simulations Plus, Inc. (NASDAQ: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced that it has released version 9.6 of its flagship PBPK modeling program, GastroPlus™.

  May 23, 2018

   · 

  4 min read
• Policy

  FDA takes action against the use of OTC benzocaine teething products due to serious safety risk, lack of benefit

  Agency urges companies to discontinue teething products, include new warnings for other OTC benzocaine products and revise warnings for approved prescription local anesthetic drugs

  May 23, 2018

   · 

  5 min read
• Drug Development

  Otsuka and Lundbeck to Start Third Phase 3 Trial in June to Evaluate Brexpiprazole in the Treatment of Agitation in Patients with Alzheimer’s Disease

  Otsuka Pharmaceutical Company, Ltd. (Otsuka) and Lundbeck announce that the two companies’ third clinical Phase 3 study of brexpiprazole in the treatment of agitation in patients with dementia of the Alzheimer’s type will commence in June.

  May 23, 2018

   · 

  11 min read
• Deals

  Takeda Announces Information Related to its Pending Voluntary and Conditional Public Takeover Bid for Outstanding Shares and American Depositary Shares of TiGenix

  Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced information related to its previously announced and ongoing tender offer (the “Bid”) in cash for all outstanding ordinary shares (“Ordinary Shares”), warrants (“Warrants”) and American Depositary Shares (“ADSs”) of TiGenix.

  May 23, 2018

   · 

  9 min read
• Business

  Mainstay Medical Announces CFO Transition

  Mainstay Medical International plc announces that Mr. Hugh Kavanagh is to step down as Chief Financial Officer (“CFO”) and leave Mainstay with effect from 21 August 2018.

  May 23, 2018

   · 

  5 min read
• Grail Raises $300 Million from China Investors for Early Cancer Diagnostics

  Grail announced a $300 million C financing. Since early 2016, Grail has raised over $1.5 billion.

  May 23, 2018

   · 

  1 min read
• Drug Development

  Berlin Cures Announces Formation of Scientific Advisory Board

  Drug developer Berlin Cures today announced the formation of a Scientific Advisory Board (SAB) and the appointment of its first two members, Prof. Beda M. Stadler and Prof. Wilhelm Vetter.

  May 23, 2018

   · 

  4 min read
• Business

  CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease

  Centogene, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced a clinical development collaboration with Orphazyme A/S.

  May 23, 2018

   · 

  3 min read
• Drug Development

  Robocath demonstrates safety and efficacy of its R-OneTM medical robotic platform

  Robocath announces during the EuroPCR congress that its first robotic solution, R-OneTM, met all its primary efficacy and safety endpoints in the first pre-clinical study.

  May 23, 2018

   · 

  2 min read
• BioMidwest

  Kraig Biocraft Laboratories Develops New Breakthrough Spider Silk DNA Synthesis Protocols Accelerating Time to Market for New Products

  Kraig Labs’ R&D team raises the bar in transgenic research.

  May 23, 2018

   · 

  3 min read